SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-102291
Filing Date
2016-05-16
Accepted
2016-05-16 12:31:33
Documents
57
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v438591_10q.htm 10-Q 287958
2 EXHIBIT 31.1 v438591_ex31-1.htm EX-31.1 10192
3 EXHIBIT 31.2 v438591_ex31-2.htm EX-31.2 10165
4 EXHIBIT 32.1 v438591_ex32-1.htm EX-32.1 5028
5 EXHIBIT 32.2 v438591_ex32-2.htm EX-32.2 5034
  Complete submission text file 0001144204-16-102291.txt   3519598

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT antb-20160331.xml EX-101.INS 621093
7 XBRL TAXONOMY EXTENSION SCHEMA antb-20160331.xsd EX-101.SCH 43930
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20160331_cal.xml EX-101.CAL 39217
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20160331_def.xml EX-101.DEF 298090
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20160331_lab.xml EX-101.LAB 332733
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20160331_pre.xml EX-101.PRE 327035
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54495 | Film No.: 161652121
SIC: 2834 Pharmaceutical Preparations